Webinar Recordings about Drug Resistant Epilepsy Treatment Options
Epilepsy News From: Monday, November 26, 2018
For approximately 1 in 3 people living with epilepsy, seizures cannot be controlled by antiseizure medication. Understanding what options are available to further evaluate your epilepsy and to aid in treating drug resistant seizures is critical to improving outcome and quality of life. Timely referral to an epilepsy center is important. Below are some of the reasons why finding the best care with an epilepsy team of specialists is necessary.
If you have epilepsy or care for or about people with epilepsy, listen to two new webinars focused on evaluation and treatment options for people with uncontrolled epilepsy, also called drug resistant epilepsy. These will help you learn about the journey through an epilepsy center for a surgical evaluation and neurostimulation devices.
When Medications Fail: Presurgical Evaluation in Drug Resistant Epilepsy
Initially presented on October 24, 2018, with Dr. David Ficker, Professor of Neurology, University of Cincinnati Gardner Neurosciences Institute, and Mimi Callanan, RN, MSN, ACNS, Epilepsy Clinical Nurse Specialist, Stanford Comprehensive Epilepsy Center
Neurostimulation in the Treatment of Drug Resistant Epilepsy
First presented on November 6, 2018, with Dr. Lawrence Hirsch, Professor of Neurology and Chief, Division of Epilepsy and EEG at Yale Comprehensive Epilepsy Center; Kimberly Bari from California; and MaryAnn Widener from New Hampshire
Learn More
We hope you will access these learning opportunities and share them with others in your local epilepsy communities.
- Visit learn.epilepsy.com to access these free webinars and other learning opportunities. Click on "training catalogue" to view training and education options before logging in or creating a user account.
- Find an Epilepsy Center
- Learn more about the National Association of Epilepsy Centers
*These Epilepsy Foundation webinars on drug resistant epilepsy were supported in part by funding from NeuroPace, Inc.
Authored by
Elaine Kiriakopoulos MD, MSc
Reviewed Date
Monday, November 26, 2018